• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Thoma Bravo to buy majority of Centrify

Share:

July 15, 2018

Thoma Bravo, a leading private equity investment firm, today announced it will acquire a majority interest in Centrify, the market-leading next-generation Identity & Access Management platform, from its venture capital investors, led by Mayfield, Accel Partners, Jackson Square Ventures and Index Ventures. The transaction is expected to close in the third quarter of this year, subject to usual and customary closing conditions and regulatory approvals. Financial details of the transaction were not disclosed.

According to the 2018 Verizon Data Breach Investigations Report, compromised user identities is the top cybersecurity attack vector, and with the shift to cloud computing by enterprises, cloud security risks such as password sprawl and privileged access management are expected to accelerate. Centrify meets these challenges as the only “Leader” in both The Forrester Wave™ Privileged Identity Management and Identity-As-A-Service reports. By converging these solutions into a unified Next-Gen Access platform for Zero Trust Security, Centrify is well-positioned as an early entrant and cybersecurity innovator of next generation technology that protects its customers’ assets and access to information from external and internal cyber threats.

Founded in 2004 and headquartered in Santa Clara, California, Centrify serves over five thousand customers spanning the public and private sectors, including blue-chip Global 2000s, across diverse industries including defense, banking, energy, retail, manufacturing and health care.

“Centrify has seen tremendous growth, and joining with an experienced partner like Thoma Bravo not only ensures we take advantage of existing market opportunities, but also positions us to continue to lead in this growing industry,” said Tom Kemp, co-founder and CEO of Centrify. “With Thoma Bravo’s extensive sector experience and insight in the enterprise security software space, Centrify is in a strong position to provide our products, services and unique expertise to meet the rising need for identity-based cybersecurity technology in today’s global environment.”
Thoma Bravo, an established investor in enterprise security software, has successfully partnered with other innovators in the growing identity space, including Bomgar and SailPoint. The firm’s longtime experience investing in the sector and ability to build a productive partnership with a company’s existing management differentiates them within the private equity community.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Having invested successfully several times in the identity market, we’ve known and watched Centrify as a leader for many years, and we absolutely share the company’s vision on where the market is headed,” said A.J. Rohde, a partner at Thoma Bravo. “We are unbelievably excited to partner with Tom Kemp and his world-class team to continue to disrupt and expand the identity market organically and through M&A, all while partnering with the team to help institute our best-in-class processes.”

“Centrify is unique in that it offers products across the entire continuum of identity access management through a cutting-edge, natively built cloud platform,” said Carl Press, a principal at Thoma Bravo. “We see opportunities to both strengthen its leadership position within the privileged identity market as well as accelerate its growth in single sign-on and multi-factor authentication.”

Kirkland & Ellis is serving as Thoma Bravo’s legal advisor, and Golub Capital is providing financing for the transaction. Sidley Austin is Centrify’s legal advisor, and Barclays is serving as its financial advisor.

Date: July 16, 2018

Source: PeHub Network

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Capital Rx Raises $12M to Bring Transparency to Pharmacy BenefitsCapital Rx Raises $12M to Bring Transparency to Pharmacy Benefits
  • CareDx Agrees to Acquire Transchart and Expands EMR Connectivity to Over 90 Centersacquisition Will Build on CareDx’s Digital Capabilities and Continue Deepening the Moat with Transplant CentersCareDx Agrees to Acquire Transchart and Expands EMR Connectivity to Over 90 Centersacquisition Will Build on CareDx’s Digital Capabilities and Continue Deepening the Moat with Transplant Centers
  • Sen. Elizabeth Warren Urges FTC to Review CVS’ Oak Street Health DealSen. Elizabeth Warren Urges FTC to Review CVS’ Oak Street Health Deal
  • mPulse Acquires HealthTrio and Decision PointmPulse Acquires HealthTrio and Decision Point
  • Using Patient Relationship Management Tools to Improve Preventive & Chronic CareUsing Patient Relationship Management Tools to Improve Preventive & Chronic Care
  • Wheel Raises $150M to Expand White-Labeled Virtual Care ServicesWheel Raises $150M to Expand White-Labeled Virtual Care Services
  • LumiraDx to Sell Point of Care Technology Platform to Roche for $295M.LumiraDx to Sell Point of Care Technology Platform to Roche for $295M.
  • CMS Launches $1.65M Artificial Intelligence Health Outcomes ChallengeCMS Launches $1.65M Artificial Intelligence Health Outcomes Challenge

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications